Articles Archives - Page 2 of 2

COVID-19 Vaccination 2025–2026 (JN.1) Guide for Pharmacies & Patients

Introduction For the 2025–2026 respiratory season, the U.S. Food and Drug Administration (FDA) has authorized a new monovalent COVID-19 vaccine based on the JN.1 lineage of SARS-CoV-2, with preference for the LP.8.1 subvariant. As the United States enters the fifth year of post-pandemic COVID-19 management, vaccination strategy has shifted from emergency response to seasonal preparedness. […]

COVID-19 Vaccination 2025–2026 (JN.1) Guide for Pharmacies & Patients Read More »

Decongestion Pills Are Changing in 2025: Why Oral Phenylephrine Is Being Phased Out and What Works Instead

Articles / Fannie Pena

Introduction For decades, over-the-counter “decongestion pills” have been a routine remedy for stuffy noses caused by colds, allergies, or sinus infections. The main ingredient in many of these products (phenylephrine) became the default after pseudoephedrine was moved behind the pharmacy counter in the mid-2000s. But in late 2024, the U.S. Food and Drug Administration (FDA)

Decongestion Pills Are Changing in 2025: Why Oral Phenylephrine Is Being Phased Out and What Works Instead Read More »

Home Combination Tests for COVID and Influenza: Molecular vs. Antigen

Leave a Comment / Articles / Fannie Pena

Introduction Cold and flu season has always been unpredictable, but since COVID-19 entered the picture, the overlap of respiratory infections has become a year-round concern. Fever, fatigue, sore throat, and congestion could indicate influenza, COVID-19, or both, and relying on symptoms alone is no longer enough. The FDA’s authorization of over-the-counter (OTC) combination home tests

Home Combination Tests for COVID and Influenza: Molecular vs. Antigen Read More »